Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 7/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | RHEB | Q15382 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CRHBP | P24387 | 1/20 | 0.30 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31317053 | 0.82 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3CES2CES1 | |
| SCHEMBL11940797 | 0.82 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3CES2CES1 | |
| SCHEMBL106795 | 0.82 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3CES2CES1 | |
| SCHEMBL290116 | 0.80 | L3MBTL1 (0.41) | SLC6A2SLC6A3HTR1ANFE2L2RHEB | |
| SCHEMBL288166 | 0.78 | CES2 (0.34) | CES2CES1 | |
| SCHEMBL518108 | 0.77 | CA1 (0.44) | NFE2L2L3MBTL1TDP1KDM4EMAPT | |
| SCHEMBL521826 | 0.77 | MRGPRX4 (0.40) | SLC6A2SLC6A4SLC6A3HTR1A | |
| SCHEMBL14237478 | 0.77 | SLC6A2 (0.33) | SLC6A2SLC6A4SLC6A3HTR1A | |
| SCHEMBL2784082 | 0.77 | ACHE (0.36) | SLC6A2SLC6A4SLC6A3TRPA1HTR1A | |
| SCHEMBL14719203 | 0.77 | ALB (0.41) | CES2CES1L3MBTL1TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333383-A1 | N-OXIDE COMPOUNDS AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2025-10-30 | — | — | US | disclosed |
| EP-4514777-A1 | N-OXIDE COMPOUNDS AND USE THEREOF | SK Biopharmaceuticals Co., Ltd. (KR) | 2025-03-05 | — | — | EP | disclosed |
| US-20250059207-A1 | 6,6-FUSED HETEROCYCLIC COMPOUNDS AS METTL3 INHIBITORS | 858 THERAPEUTICS, INC. | 2025-02-20 | — | — | US | disclosed |
| WO-2023211195-A1 | N-OXIDE COMPOUNDS AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023129933-A2 | 6,6-FUSED HETEROCYCLIC COMPOUNDS AS METTL3 INHIBITORS | 858 THERAPEUTICS, INC. (US) | 2023-07-06 | — | — | WO | disclosed |
| EP-3276697-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE AND COMPOUND | IDEMITSU KOSAN CO (JP) | 2020-08-26 | — | — | EP | disclosed |
| US-10547009-B2 | Organic electroluminescent element, electronic device and compound | IDEMITSU KOSAN CO., LTD. (JP) | 2020-01-28 | — | — | US | disclosed |
| EP-2949655-B1 | REACTION CATALYST FOR CROSS COUPLING AND METHOD FOR MANUFACTURING AROMATIC COMPOUND | HOKKO CHEM IND CO (JP) | 2019-05-15 | — | — | EP | disclosed |
| US-10246422-B2 | Heterocyclic compounds and use thereof in medicine and in cosmetics | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2019-04-02 | — | — | US | disclosed |
| CN-108884043-A | Substituted piperidine compounds and uses thereof | 武田药品工业株式会社 | 2018-11-23 | — | — | CN | disclosed |
| WO-2001029012-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-04-26 | — | — | WO | disclosed |
| WO-2000077001-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |
| US-5702642-A | ACRYLIC ESTER POLYMERS; BRIGHTNESS IN ABSENCE OF ELECTRIC VOLTAGE | SHARP KABUSHIKI KAISHA (JP) | 1997-12-30 | — | — | US | disclosed |
| US-5645760-A | Polymeric compounds, and liquid crystal element using the same | SHARP KABUSHIKI KAISHA (JP) | 1997-07-08 | — | — | US | disclosed |
| EP-0637624-B1 | Antiferroelectric liquid crystal compound | SHOWA SHELL SEKIYU (JP) | 1996-09-25 | — | — | EP | disclosed |
| US-5543075-A | ANISOTROPIC GEL CONTAINING LIQUID CRYSTAL POLYMER WHICH FORMS PERMANENTLY ORIENTED NETWORK IN LOW MOLECULAR WEIGHT DIELECTRIC LIQUID CRYSTALLINE MATERIAL, DISPLAY CELLS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1996-08-06 | — | — | US | disclosed |
| US-5417885-A | Antiferroelectric liquid crystal compound | SHOWA SHELL SEKIYU KABUSHIKI KAISHA (JP) | 1995-05-23 | — | — | US | disclosed |
| EP-0637624-A1 | Antiferroelectric liquid crystal compound | Showa Shell Sekiyu Kabushiki Kaisha (JP) | 1995-02-08 | — | — | EP | disclosed |
| EP-0615630-A1 | LIQUID CRYSTALLINE MATERIAL | MERCK PATENT GmbH (DE) | 1994-09-21 | — | — | EP | disclosed |
| WO-1994008268-A1 | LIQUID CRYSTALLINE MATERIAL | MERCK PATENT GMBH (DE) | 1994-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333383-A1 | N-OXIDE COMPOUNDS AND USE THEREOF | SCNN1B, SCN1B, SCN2B | SLC6A2 51/4885SLC6A4 146/4885SLC6A3 182/4885 |
| US-20250059207-A1 | 6,6-FUSED HETEROCYCLIC COMPOUNDS AS METTL3 INHIBITORS | METTL3, METTL16, TPMT | SLC6A2 1229/4885SLC6A4 744/4885SLC6A3 374/4885 |
| US-10246422-B2 | Heterocyclic compounds and use thereof in medicine and in cosmetics | MC1R, BDKRB2, CCKBR | SLC6A2 1286/4885SLC6A4 1556/4885SLC6A3 2325/4885 |
| US-10547009-B2 | Organic electroluminescent element, electronic device and compound | LEF1, FRG1, CTNNA1 | SLC6A2 3139/4885SLC6A4 3597/4885SLC6A3 3879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.